Nevertheless, our integrated network pharmacology and untargeted metabolomics approach identified high-confidence targets (e.g., STAT3, GSH metabolism) associated with inflammatory skin diseases such as psoriasis, supporting the translational potential of β-Acetoxyisovalerylalkannin. The gene discussed is STAT3; the disease is inflammatory skin disease.